Literature DB >> 4799552

In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.

S Shadomy, C B Kirchoff, A E Ingroff.   

Abstract

One hundred yeasts were studied. Tests included detailed identification and determination of 24- and 48-hr minimal inhibitory concentrations and minimal fungicidal concentrations of 5-fluorocytosine (5-FC). Final identifications included 57 isolates of Candida albicans, 15 isolates of C. tropicalis, 13 isolates of C. parapsilosis, 7 isolates of Torulopsis glabrata, 3 isolates of C. guilliermondii, 2 isolates each of C. stellatoidea and Cryptococcus neoformans, and 1 isolate of Candida krusei. Twenty-three original identifications were in error; these involved mostly C. albicans, C. tropicalis, C. parapsilosis, and T. glabrata. Inhibitory end point readings based on 24 hr of incubation were misleading. Whereas 79 of 91 isolates of Candida appeared to be inhibited at 24 hr by 12.5 mug or less of 5-FC/ml, only 52 were inhibited at 48 hr; whereas only 12 isolates appeared to be resistant to 100 mug/ml after 24 hr, 37 were resistant after 48 hr. Susceptibility varied amount the different species. C. tropicalis was the most susceptible, with 10 of 15 isolates (66.7%) being inhibited by 12.5 mug or less/ml and 7 (46.7%) being killed by 100 mug or less/ml. C. albicans was similarily susceptible; 33 of 57 isolates (57.9%) were inhibited by 12.5 mug or less/ml and 25 (43.9%) were killed by 100 mug or less/ml. C. parapsilosis was quite resistant, as only 4 of 13 isolates (30.8%) were inhibited by 12.5 mug or less/ml and 3 (23.1%) were killed by 100 mug or less/ml.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4799552      PMCID: PMC444352          DOI: 10.1128/AAC.3.1.9

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

Authors:  P L Steer; M I Marks; P D Klite; T C Eickhoff
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

2.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

3.  Further in vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

  3 in total
  13 in total

1.  Susceptibility and resistance of Candida to 5-fluorocytosine in relation to the cell wall ultrastructure.

Authors:  S Montplaisir; B Nabarra; E Drouhet
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 3.  Antifungal drug susceptibility testing. A critical review.

Authors:  D A Stevens
Journal:  Mycopathologia       Date:  1984-09-30       Impact factor: 2.574

4.  Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.

Authors:  A S Bayer; J E Edwards; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.

Authors:  G V Doern; T A Tubert; K Chapin; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 6.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

7.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.

Authors:  D L Calhoun; G D Roberts; J N Galgiani; J E Bennett; D S Feingold; J Jorgensen; G S Kobayashi; S Shadomy
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

Review 9.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Disk agar diffusion susceptibility testing of yeasts.

Authors:  M A Saubolle; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.